4 free views remaining today

primary coenzyme Q10 deficiency 2

Description

Primary Coenzyme Q10 Deficiency: A Rare and Clinically Heterogeneous Disorder

Primary coenzyme Q10 (CoQ10) deficiency is a rare, autosomal recessive disorder caused by mutations in genes involved in the CoQ10 biosynthetic pathway. This condition can affect various parts of the body, particularly the brain, muscles, and kidneys.

Clinical Manifestations

The clinical manifestations of primary CoQ10 deficiency are diverse and range from fatal neonatal onset multisystemic disease to a relatively mild, late-onset form. The symptoms can include:

  • Central nervous system symptoms: hypotonia, ataxia, retinopathy, parkinsonism
  • Muscular symptoms: muscle weakness, wasting, and cramps
  • Kidney symptoms: kidney failure, electrolyte imbalances

Causes

Primary CoQ10 deficiency is caused by genetic defects in the multi-step biochemical pathway of CoQ10 synthesis. This can result from mutations in any of the genes encoding proteins directly involved in CoQ10 biosynthesis.

References

  • [1] Primary coenzyme Q10 deficiency is a disorder that can affect many parts of the body, especially the brain, muscles, and kidneys.
  • [2] by D Mantle · 2023 · Cited by 15 — Primary CoQ10 deficiency results from mutations in genes involved in the CoQ10 biosynthetic pathway.
  • [5] Primary CoQ10 deficiency is a rare, clinically heterogeneous autosomal recessive disorder caused by mutation in any of the genes encoding proteins directly ...
  • [6] by I Hargreaves · 2020 · Cited by 154 — Primary deficiencies result from genetic defects in the multi-step biochemical pathway of CoQ10 synthesis, whereas secondary deficiencies can ...

Additional Characteristics

  • Primary coenzyme Q10 (CoQ10) deficiency is a rare, autosomal recessive disorder caused by mutations in genes involved in the CoQ10 biosynthetic pathway.
  • The clinical manifestations of primary CoQ10 deficiency are diverse and range from fatal neonatal onset multisystemic disease to a relatively mild, late-onset form.
  • Primary CoQ10 deficiency is caused by genetic defects in the multi-step biochemical pathway of CoQ10 synthesis.
  • This can result from mutations in any of the genes encoding proteins directly involved in CoQ10 biosynthesis.

Signs and Symptoms

Primary Coenzyme Q10 Deficiency Signs and Symptoms

Primary coenzyme Q10 (CoQ10) deficiency can manifest in various ways, affecting different parts of the body. The symptoms can range from mild to severe and may vary depending on the individual case.

  • Neurological issues: Encephalopathy, characterized by severe brain dysfunction, is a common symptom [1]. Other neurological problems include muscle weakness, coordination problems, and ataxia (loss of coordination) [7].
  • Muscle weakness: Muscle myopathy, which affects the muscles' ability to function properly, can also occur [3].
  • Cardiovascular issues: Hypertrophic cardiomyopathy, a condition where the heart muscle becomes thickened, can be a symptom [3].
  • Kidney problems: Nephrotic syndrome, a kidney disorder characterized by excessive protein loss in the urine, can be associated with CoQ10 deficiency [2].
  • Other symptoms: In severe cases, primary CoQ10 deficiency can lead to infantile multisystemic disease, which affects multiple body systems simultaneously [6].

It's essential to note that the severity and presentation of these symptoms can vary widely among individuals. If you suspect a primary coenzyme Q10 deficiency, consult with a healthcare professional for proper diagnosis and treatment.

References: [1] CM Quinzii ·

Additional Symptoms

  • Nephrotic syndrome
  • Encephalopathy
  • Hypertrophic cardiomyopathy
  • Coordination problems
  • Infantile multisystemic disease
  • ataxia
  • muscle weakness

Diagnostic Tests

Diagnostic Tests for Primary Coenzyme Q10 Deficiency

Primary coenzyme Q10 (CoQ10) deficiency is a disorder that can affect various parts of the body, including the brain, muscles, and kidneys. Diagnosing this condition requires specific tests to measure CoQ10 levels in different tissues.

  • Muscle Biopsy: The most reliable test for diagnosing primary defects in ubiquinone (CoQ10) biosynthesis is direct measurement of CoQ10 in muscle tissue [7]. This involves taking a small sample of muscle tissue from the affected area.
  • Fibroblast Testing: Measuring CoQ10 levels in fibroblasts, which are skin cells, can also be an effective diagnostic tool [4].
  • Blood Tests: While blood tests may not be as reliable for diagnosing primary CoQ10 deficiency, they can still provide useful information. Initial biochemical testing should include measurement of blood lactate levels, although a normal lactate level does not exclude CoQ10 deficiency [3].

It's essential to note that diagnosis is often made by analyzing multiple genes simultaneously using genetic testing [9]. This helps in differential diagnosis and identifying the underlying cause of the condition.

References:

[1] Context result 7 [2] Context result 4 [3] Context result 3 [7] Context result 7 [9] Context result 9

Additional Diagnostic Tests

  • Blood Tests
  • Muscle Biopsy
  • Fibroblast Testing

Treatment

Treatment Options for Primary Coenzyme Q10 Deficiency

Primary coenzyme Q10 (CoQ10) deficiency can be treated with high-dose oral CoQ10 supplementation, but not all patients respond to this treatment. According to search result [1], the FDA granted rare pediatric disease designation to BPM31510IV (BPGbio), an investigational treatment for primary coenzyme Q10 (CoQ10) deficiency.

Early Supplementation Crucial

Search result [3] highlights the importance of early CoQ10 supplementation for the success of therapy. This is due to

Recommended Medications

  • High-dose oral CoQ10 supplementation
  • BPM31510IV

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Primary Coenzyme Q10 Deficiency

Primary coenzyme Q10 (CoQ10) deficiency is a rare genetic disorder that affects the production of CoQ10, an essential energy-producing molecule in cells. The differential diagnosis of primary CoQ10 deficiency involves considering other conditions that may present with similar symptoms.

Conditions to Consider:

  • Mitochondrial disorders: These are a group of diseases caused by defects in the mitochondria, the energy-producing structures within cells. Mitochondrial disorders can cause a range of symptoms, including muscle weakness, seizures, and ataxia (loss of coordination).
  • Friedreich's ataxia: This is a genetic disorder that affects the production of CoQ10 and other mitochondrial proteins. It causes progressive damage to the nervous system, leading to symptoms such as ataxia, muscle weakness, and hearing loss.
  • Kearns-Sayre syndrome: This is a rare genetic disorder that affects the mitochondria in muscles and other tissues. It can cause symptoms such as muscle weakness, seizures, and vision problems.
  • Myotonic dystrophy: This is a genetic disorder that affects the production of CoQ10 and other mitochondrial proteins. It causes progressive muscle wasting and weakness.

Key Findings to Differentiate:

  • Biochemical testing: The following findings on biochemical testing can differentiate CoQ10 deficiency from other mitochondrial disorders with similar clinical findings, but cannot rule out other conditions:
    • Low levels of CoQ10 in tissues
    • Elevated levels of lactate and pyruvate in blood
    • Abnormalities in muscle biopsy (e.g., ragged-red fibers)
  • Genetic testing: Genetic testing can confirm the diagnosis of primary CoQ10 deficiency by identifying mutations in the COQ2, COQ4, or other genes involved in CoQ10 biosynthesis.

References:

  • [6] The following findings on biochemical testing can differentiate CoQ10 deficiency from other mitochondrial disorders with similar clinical findings, but cannot rule out other conditions.
  • [8] Primary CoQ10 deficiency is a potentially important cause of familial ataxia and should be considered in the differential diagnosis of this condition.
  • [9] Pathogenic variants in any of the genes involved in the biosynthetic pathway of coenzyme Q10 can result in a primary CoQ10 deficiency phenotype; therefore, genetic testing is essential for accurate diagnosis.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2111
owl#annotatedSource
t349705
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070239
core#notation
DOID:0070239
oboInOwl#hasDbXref
ORDO:254898
IAO_0000115
A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the PDSS1 gene on chromosome 10p12.1.
oboInOwl#hasExactSynonym
hearing loss-encephaloneuropathy-obesity-valvulopathy syndrome
rdf-schema#label
primary coenzyme Q10 deficiency 2
rdf-schema#subClassOf
t349456
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
RO_0004019
http://purl.obolibrary.org/obo/SO_0001537
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.